首页> 外文期刊>Stroke: A Journal of Cerebral Circulation >Intravenous versus combined (intravenous and intra-arterial) thrombolysis in acute ischemic stroke: a transcranial color-coded duplex sonography--guided pilot study.
【24h】

Intravenous versus combined (intravenous and intra-arterial) thrombolysis in acute ischemic stroke: a transcranial color-coded duplex sonography--guided pilot study.

机译:急性缺血性卒中的静脉溶栓与联合(静脉和动脉内)溶栓治疗:经颅彩色编码的双工超声检查指导的试验研究。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND AND PURPOSE: Determine feasibility and safety of intravenous (IV) versus combined (IV-IA [intra-arterial]) thrombolysis guided by transcranial color-coded duplex sonography (TCCD). METHODS: Thirty-three patients eligible for IV thrombolysis, within 3 hours of onset of symptoms, with occlusion in middle cerebral artery territory (TCCD monitoring, thrombolysis in brain ischemia [TIBI] flow grade [0-3]), underwent IV thrombolysis (tissue plasminogen activator, 0.9 mg/kg). In case of recanalization (modification of TIBI score > or =1) after 30 minutes IV thrombolysis was continued over 1 hour; otherwise, it was discontinued, with subsequent IA thrombolysis. Recanalization was determined by TIBI (TCCD) and angiographically by thrombolysis in myocardial infarction (TIMI) flow grades. Clinical outcome measures were assessed at baseline, 24 hours (NIHSS) and 3 months (modified Rankin Scale). RESULTS: In the IV group, 10/17 patients (59%) with complete or partial recanalization after 30 minutes had afavorable outcome at 3 months (modified Rankin Scale 0 to 2). TIBI flow grades 3 to 5 after 30 minutes of IV thrombolysis predicted a good prognosis compared with TIBI grades 1 to 2 (P<0.05). In the combined IV/IA therapy group (no recanalization after 30 minutes), 9/16 patients (56%) had a favorable outcome at 3 months. One symptomatic intracerebral hemorrhage occurred in each group. CONCLUSIONS: Combined IV-IA versus IV thrombolysis guided by TCCD was feasible and safe. Recanalization after 30 minutes of IV thrombolysis led to a favorable outcome in 59% of the patients, provided TIBI flow grades were of 3 to 5. In the absence of early recanalization during IV thrombolysis, there was clinical benefit to proceed to IA therapy for a significative proportion of patients (56%).
机译:背景与目的:确定经颅彩色编码双工超声(TCCD)引导的静脉(IV)与联合(IV-IA [动脉内])溶栓的可行性和安全性。方法:33名符合IV溶栓治疗标准的患者在症状发作后3小时内闭塞在大脑中动脉区域(TCCD监测,脑缺血血栓溶解度[TIBI]血流等级[0-3]),进行了IV溶栓治疗(组织纤溶酶原激活剂(0.9 mg / kg)。如果在30分钟后重新通气(TIBI评分修改为>或= 1),则静脉溶栓持续1小时以上;否则,停药,随后进行IA溶栓。重新通气由TIBI(TCCD)决定,通过心肌梗死(TIMI)血流溶解程度通过血管造影确定。在基线,24小时(NIHSS)和3个月(改良Rankin量表)中评估临床结局指标。结果:在静脉输液组中,有10/17例患者(59%)在30分钟后完全或部分再通,在3个月时有良好的预后(改良兰金等级0至2)。静脉溶栓30分钟后,TIBI血流等级3到5与TIBI血流等级1到2相比预示良好的预后(P <0.05)。在IV / IA联合治疗组(30分钟后未再通气)中,9/16例患者(56%)在3个月时有良好的预后。每组发生1例症状性脑出血。结论:由TCCD指导的IV-IA与IV溶栓联合治疗是可行且安全的。如果TIBI血流级别为3到5,则静脉溶栓30分钟后再通可导致59%的患者获得良好的预后。如果在静脉溶栓期间无早期再通的情况下,进行IA疗法对患者有临床益处。患者的显着比例(56%)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号